2018
DOI: 10.1016/j.dld.2018.03.028
|View full text |Cite
|
Sign up to set email alerts
|

Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients

Abstract: Results show a combination of biochemical markers and autoantibodies associated to mixed cryoglobulinemia; these findings could be further investigated in order to ascertain their usefulness in assessing the risk for the development of mixed cryoglobulinemia.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
13
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
1
1

Relationship

3
4

Authors

Journals

citations
Cited by 12 publications
(14 citation statements)
references
References 28 publications
1
13
0
Order By: Relevance
“…Infections, autoimmunity and cancer have been implicated as determinants of etiology in MC however; HCV is the most frequent infectious trigger (Gulli et al, 2017, Basile et al, 2018a, 2018b.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Infections, autoimmunity and cancer have been implicated as determinants of etiology in MC however; HCV is the most frequent infectious trigger (Gulli et al, 2017, Basile et al, 2018a, 2018b.…”
Section: Introductionmentioning
confidence: 99%
“…Due to the complex virus-host interactions, MC represents an excellent model to investigate the pathogenetic mechanisms of HCV infection and its evolution into autoimmune/lymphoproliferative disorders that are still poorly understood (Basile et al, 2018a(Basile et al, , 2018b. The clinical spectrum of MC is extremely wide, ranging from completely asymptomatic forms without vasculitis to life-threatening complications; the worsening evolution into B cell Non-Hodgkin's Lymphoma (B-NHL) occurs in about 10% of cases (Ramos-Casals et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…The right strategy (drug and treatment) is the goal for a personalized medicine. Recently, we described different patterns of immunological biomarkers and liver fibrosis stage in HCV‐positive patients with type II and III MC . In the present study, analyzing serum samples from 79 HCV patients through a panel of biomarkers including FLCs, we aimed to identify different serological profiles as predictive factors between asymptomatic, with low levels, and symptomatic HCV patients exhibiting high levels of CGs.…”
Section: Introductionmentioning
confidence: 93%
“…Cryoglobulins (CGs) are antibodies that precipitate in vitro at temperatures below 37°C and dissolve after rewarming ( 26 , 32 , 33 ). Their precipitation in vivo can cause vasculitis of small and medium-sized vessels in the skin, joints, nerves and kidneys ( 26 ), and consequently signs and symptoms such as intermittent purpura, livedo, leg ulcers, acrocyanosis, Raynaud’s phenomenon, arthralgias, and symptoms due to peripheral neuropathy ( 26 , 34 , 35 ).…”
Section: Introductionmentioning
confidence: 99%